Free Trial

Biotricity Q2 2024 Earnings Report

Biotricity logo
$0.28 -0.01 (-4.08%)
(As of 12/20/2024 05:55 PM ET)

Biotricity EPS Results

Actual EPS
-$0.44
Consensus EPS
-$0.34
Beat/Miss
Missed by -$0.10
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$2.89 million
Expected Revenue
$3.30 million
Beat/Miss
Missed by -$410.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Q2 2024
Time
N/A
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

Biotricity Earnings Headlines

Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Biotricity Inc BTCY
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (OTCMKTS:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat

Upcoming Earnings